ライフサイエンスコーパス: visual field defect

1 e, arm, or leg weakness, speech disturbance, visual field defect).

2 for some of the impairments caused by their visual field defect.

3 iable method for determining the severity of visual field defect.

4 mal visual fields from those who developed a visual field defect.

5 n after taking into account the magnitude of visual field defect.

6 l rim thinning, RNFL loss, and corresponding visual field defect.

7 ide a more representative view of the actual visual field defect.

8 ) have slow-to-moderate progression of their visual field defects.

9 judged the similarity and the extent of the visual field defects.

10 sual field asymmetry and summary measures of visual field defects.

11 e spatial extent and absolute sensitivity of visual field defects.

12 s that may be useful in spatially localizing visual field defects.

13 ng the infusion air may reduce postoperative visual field defects.

14 ere younger, more myopic and had more severe visual field defects.

15 uces both the development and progression of visual field defects.

16 until development of repeatable glaucomatous visual field defects.

17 using singleton results and confirmation of visual field defects.

18 retinal ganglion cells (RGCs) and subsequent visual field defects.

19 kness estimates could predict development of visual field defects.

20 matous optic nerve damage with corresponding visual field defects.

21 the diagnosis and monitoring of glaucomatous visual field defects.

22 displayed glaucomatous optic neuropathy with visual field defects.

23 effects cause headache, hypopituitarism, and visual field defects.

24 y, and pupillary defect were associated with visual field defects.

25 hich corresponds to subjective and objective visual field defects.

26 visual field defects, and 7 (50%) had severe visual field defects.

27 ic stimuli are insensitive for demonstrating visual field defects.

28 such as FF120 may be useful for detection of visual field defects.

29 visual field defects, and 6 (43%) had severe visual field defects.

30 diction with a significantly reduced risk of visual field defects.

31 t pupillary defects, optic nerve pallor, and visual field defects.

32 dentified a comparable number of clusters of visual field defects.

33 rge role in the rehabilitation of homonymous visual field defects.

34 ations in the AH than did patients with mild visual field defects.

35 r detecting mild-stage glaucoma with central visual-field defects.

36 defects in mild-stage glaucoma with central visual-field defects.

37 initial diagnosis, 4 of 14 eyes (28%) had no visual field defect, 4 (28%) had early visual field defe

38 inal follow-up, 3 of 14 eyes (21%) had early visual field defects, 4 (29%) had moderate visual field

39 64%), pale optic discs (65% versus 27%) and visual field defects (72% versus 30%) could be observed

40 r-old woman had left eye RAO and a bilateral visual field defect after CaHA injection into the glabel

41 We report a novel central/paracentral visual field defect after PPV for RRD repair.

42 Glaucoma was defined by visual field defect alone.

43 This allowed change in one pattern of visual field defect (along one axis) to be assessed rela

44 The visual field defect and corresponding anatomic ganglion

45 On worsening of visual field defect and optic disc damage, patients coul

46 The discrepancy between the visual field defect and the optic nerve head morphology,

47 There was no correlation between visual field defect and TLCPD, IOP, or ICP and in any bo

48 pathy; 70% of CRD showed absolute peripheral visual field defects and 37% of CD developed rod involve

49 lateral visual loss, but extensive bilateral visual field defects and bilateral optic nerve head swel

50 firming the established relationship between visual field defects and damage to primary visual areas

51 centric neglect report no or limited data on visual field defects and extinction.

52 e the diagnostic accuracy of FDT and MDT for visual field defects and glaucoma.

53 ed by syndromes of hormone excess as well as visual field defects and hypopituitarism from mass effec

54 SAP measures of visual field defects and OCT measures of RNFL defects ar

55 Associations between global visual field defects and predictors were examined.

56 -adapted ERGs of macaque monkeys with severe visual field defects and substantial retinal ganglion ce

57 ograms (ERGs) of macaque monkeys with severe visual field defects and substantial retinal ganglion ce

58 on cells (RGCs) in glaucoma are the cause of visual field defects and thinning of the retinal nerve f

59 l change of the optic nerve head, leading to visual field defects and ultimately blindness.

60 After significant visual field defects and/or typical clinical glaucomatou

61 ad no visual field defect, 4 (28%) had early visual field defects, and 6 (43%) had severe visual fiel

62 y visual field defects, 4 (29%) had moderate visual field defects, and 7 (50%) had severe visual fiel

63 consultations were concern for papilledema, visual field defects, and diplopia.

64 isual field global indices, identify central visual field defects, and facilitate macular structure-f

65 ted with unexplained loss of central vision, visual field defects, and/or photopsia were diagnosed wi

66 Although glaucomatous visual field defects are more common in the superior fie

67 drugs and the mechanisms that lead to these visual field defects are uncertain.

68 ted glaucoma, vertical cup-to-disc ratio and visual field defects as found on frequency doubling tech

69 29 eyes with open angle glaucoma and visual field defects, as well as 20 eyes of 10 age-match

70 Patients with symptoms of photopsias or a visual field defect at presentation were excluded.

71 All eyes had glaucomatous visual field defects at baseline.

72 a at earlier ages, sometimes with associated visual field defects at normal intraocular pressures.

73 % CI, 70%-91%) when only absolute peripheral visual field defects at standard conventional perimetry

74 ss appears to be necessary before functional visual field defects become detectable.

75 Age, gender, body mass index, severity of visual field defect, best-corrected visual acuity, and S

76 sual hallucinations or incidental homonymous visual field defect but without symptoms of increased in

77 d early (35%) or moderate (31%) glaucomatous visual field defects, but 134 subjects (33%) had advance

78 btained from rhesus monkeys with significant visual field defects caused by experimental glaucoma.

79 Visual field defects caused by glaucoma can be improved

80 n acute unilateral decrease in vision, (2) a visual field defect consistent with NAION, (3) a relativ

81 Visual field defects corresponded with ganglion cell lay

82 The visual field defect demonstrated bilateral enlarged blin

83 Subjects with severe visual field defects demonstrated the greatest odds of d

84 Subjects with severe visual field defects demonstrated the greatest odds of d

85 visually impaired by symptomatic paracentral visual field defects despite a normal VA.

86 Use of steroids, headaches, and visual field defects did not differ by dose or seizure r

87 two groups according to location of initial visual field defect (either paracentral or peripheral).

88 diation who present with sudden or transient visual field defects, even in the absence of other conve

89 Patients with homonymous visual field defects experience disabling functional imp

90 visual acuity (BCVA), fundus abnormalities, visual field defects, ffERG changes, and presence of ant

91 defects from 0.5% to 17.1% (15 studies), and visual field defects from 2.0% to 37.3% (ten studies).

92 Visual field defects gradually resolved and visual acuit

93 After significant visual field defects had developed, the retinas were col

94 Subjects with greater severity of visual field defects had greater difficulty with vision-

95 Subjects with severe visual field defects had greater odds of worrying about

96 Patients with severe visual field defects had higher IL-8 concentrations in t

97 n these defective angles and the severity of visual field defect has not been verified.

98 en the clear negative effect that homonymous visual field defect has on patients' lives, these therap

99 n approaches to rehabilitation of homonymous visual field defect have been pursued in recent years an

100 ut procedures to quantify neural losses from visual field defects have not been developed.

101 Macroadenomas may cause mass effect, such as visual field defects, headache, and/or hypopituitarism,

102 on SD OCT B-scan in all and a corresponding visual field defect in 83%.

103 He noted a nasal visual field defect in his left eye that progressed to i

104 uffered from a dyschromatopsia and a central visual field defect in the left eye.

105 he perimetry of the right eye and peripheral visual field defect in the left eye.

106 (33.5%) who underwent orthoptic evaluation, visual field defects in 32 of 114 (28.1%) with reliable

107 ms not be as efficient as the HVF in finding visual field defects in glaucoma subjects, and is theref

108 To investigate the prevalence of visual field defects in glaucomatous eyes, glaucoma susp

109 ificity similar to that of CAP for detecting visual field defects in patients with optic neuropathies

110 otentially associated with early paracentral visual field defects in primary open-angle glaucoma pati

111 requent in the U.S. POAG patients with early visual field defects in the paracentral regions compared

112 rity were defined based on visual acuity and visual fields defects in the worse eye.

113 most effective testing program for detecting visual-field defects in mild-stage glaucoma with central

114 tatus; the proportion of subjects with worse visual field defects increased with worsening myopia sev

115 nt, volunteers were randomized to 1 of the 3 visual field defects listed above.

116 Visual field defects may be detected more often by FDT a

117 o screen out patients in whom progression of visual field defects may be due to diffuse loss from cat

118 The association between myopia and visual field defects may represent an increased risk of

119 uded decreased visual acuity (n = 23 [53%]), visual field defect (n = 2 [5%]), floaters (n = 7 [16%])

120 r VEP can provide an objective assessment of visual field defects not yet present on automated perime

121 rms of glaucoma are painless and symptomatic visual-field defects occur late.

122 The most frequent neurologic complication is visual field defect occurring from temporal lobe resecti

123 Visual field defects of various depths, ranging from a s

124 from 6% to 57%, at the time of the earliest visual field defect on SAP.

125 tive database, glaucomatous ONH changes, and visual field defects on 24-2 tests.

126 All patients had repeatable visual field defects on standard automated perimetry (SA

127 eption, with 40% of patients having residual visual field defects on standard automated perimetry.

128 on the number of RGCs associated with early visual fields defects on SAP.

129 None of the deficits could be explained by a visual field defect or primary motor deficit.

130 ld contribute to different susceptibility to visual field defect or vascular dysfunction in the super

131 Patients with known visual field defects or best-corrected vision less than

132 +c) with the presence of central scotoma and visual field defect parameters, respectively.

133 resident group had more severe preoperative visual field defects, poorer long-term postoperative vis

134 The severity of glaucomatous visual field defects ranged from early to severe (averag

135 d in 2 patients, in 1 case associated with a visual field defect reduced after discontinuation of the

136 25 of 26 (96%), and 25 of 25 (100%) had 10-2 visual field defects, respectively.

137 d 2% demonstrated mild, moderate, and severe visual field defects, respectively.

138 of the central and peripheral EVC following visual field defects specifically affecting central or p

139 (kappa = 0.54 +/- 0.08) on the presence of a visual field defect than did SAP-SITA (kappa = 0.34 +/-

140 ecause of atypical optic disc morphology and visual field defects that can mimic glaucoma.

141 teristic degeneration of the optic nerve and visual field defects that is often associated with an el

142 To be classified as a hemianopic visual field defect, the abnormal test location had to b

143 is the commonest form of acquired homonymous visual field defect; the usual causes are stroke, head i

144 e AGIS score, compared with patients with no visual field defect, those with severe defects (scores 1

145 l eye counts) was compared with the depth of visual field defect (treated to control eye thresholds)

146 identify the presence of a clustered central visual field defect using similar probability criteria,

147 ) locations showed corresponding en face and visual field defects using 24-2 and custom perimetry, re

148 l perceptual learning (VPL) is implicated in visual field defect (VFD) recovery following chronic str

149 marily focused on the consequences of foveal visual field defects (VFD), yet these findings may not g

150 Visual field defects (VFDs) are detected in up to 25% of

151 Other parietal deficits included a small visual field defect, visual hallucinations, prosopagnosi

152 ents with pituitary apoplexy, improvement in visual field defects, visual acuity, and diplopia is typ

153 Partial homonymous visual field defect was detected in 80 % (8/10) of the p

154 The severity of visual field defect was determined by mean deviation (MD

155 ge RGC count estimate in the eyes with early visual field defects was 652057 +/- 115829 cells, which

156 subgroup of the glaucoma patients with early visual field defects was calculated separately.

157 Visual field defects were assessed using behavioral stat

158 Central visual field defects were associated with increased odds

159 Peripheral visual field defects were found in 28% (95% CI, 25%-31%)

160 t OP RMS in all locations studied, even when visual field defects were moderate (MD = -5 to -10 dB; P

161 Although some regions with visual field defects were not detected in the mVEP due t

162 Aphasia, agnosia, seizures and visual field defects were observed.

163 Repeatable 10-2 visual field defects were present in 89 of 180 subjects

164 Central/paracentral visual field defects were seen in 9 eyes.

165 Odds of any visual field defects were significantly increased in mil

166 Central visual-field defects were defined using 10-2 SITA Standa

167 les (such as strabismus, pale optic disc and visual field defects) were compared.

168 test is a valuable tool to detect peripheral visual field defects when standard conventional perimetr

169 A partial arcuate visual field defect with an enlarged blind spot was the

170 c was classified as symptomatic if it showed visual field defects with a mean deviation (MD) of P < 2

171 metry) and 189 subjects without glaucoma (no visual field defects with healthy-appearing optic disc a

172 with glaucoma (defined as having repeatable visual field defects with standard automated perimetry)

173 ymptoms, may have mild acuity loss, and have visual field defects, with predominantly arcuate loss an

174 ts with RP who had acuity > or =20/32 and no visual field defects within 6 degrees from the fovea.